← Back to Search

Wound vac application for Arm Wound

N/A
Waitlist Available
Led By Suhail Mithani, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 2 (day of second operative debridement)
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare the amount of infection and the need for more surgery in patients who have surgery to remove infected tissue, abscesses, or traumatic wounds.

Eligible Conditions
  • Arm Wound
  • Lower Extremity Wound
  • Soft Tissue Abscesses
  • Traumatic Wounds

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 2 (day of second operative debridement)
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 2 (day of second operative debridement) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Bio-burden as Measured by Qualitative Microbial PCR (Polymerase Chain Reaction) After First Debridement
Bio-burden as Measured by Qualitative Microbial PCR (Polymerase Chain Reaction) Prior to First Debridement
Bio-burden as Measured by Qualitative Microbial PCR (Polymerase Chain Reaction) Prior to Second Debridement

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Wound vac applicationActive Control1 Intervention
Wound vac application for open upper/lower extremity open wound
Group II: Wound vac application including irrigationActive Control1 Intervention
Wound vac application WITH irrigation for upper/lower extremity open wound

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,446 Previous Clinical Trials
3,067,824 Total Patients Enrolled
3MIndustry Sponsor
158 Previous Clinical Trials
31,479 Total Patients Enrolled
Suhail Mithani, MDPrincipal InvestigatorDuke Health System
1 Previous Clinical Trials
~1 spots leftby Nov 2025